ROTHBLATT MARTINE A (Chairperson & CEO) sold 2.8% of their position (9.50K shares) of UNITED THERAPEUTICS CORP on the open market

Open‑market sale worth $5.23M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 7 sales

ROTHBLATT MARTINE A

Filed: 10/13/2026ACC: 0001106578-26-000162

InsiderROTHBLATT MARTINE ACIK 1106578

→

IssuerUNITED THERAPEUTICS CORPCIK 1082554

DirectorOfficer· Chairperson & CEO

Since Mar 2026

-9.50K

Net shares

Net seller

$5.23M

Total sold

Open market trades

0B · 7S

Total transactions

9.50K acquired · 19K disposed

Non-Derivative Transactions8

Common Stock

Indirect

M · Option Exercise

+9.50K

Price / share

$117.76

Trade value

$1.12M

% of position

2.9%

10/12/2026

324.44K→333.94K

Common Stock

Indirect

S · Sale

−428.00

Price / share

$548.13

Trade value

$234.60K

% of position

0.1%

10/12/2026

333.94K→333.51K

Common Stock

Indirect

S · Sale

−1.33K

Price / share

$549.01

Trade value

$729.64K

% of position

0.4%

10/12/2026

333.51K→332.19K

Common Stock

Indirect

S · Sale

−2.56K

Price / share

$550.03

Trade value

$1.41M

% of position

0.8%

10/12/2026

332.19K→329.62K

Common Stock

Indirect

S · Sale

−2.63K

Price / share

$551.10

Trade value

$1.45M

% of position

0.8%

10/12/2026

329.62K→326.99K

Common Stock

Indirect

S · Sale

−1.86K

Price / share

$551.92

Trade value

$1.02M

% of position

0.6%

10/12/2026

326.99K→325.14K

Common Stock

Indirect

S · Sale

−558.00

Price / share

$552.93

Trade value

$308.53K

% of position

0.2%

10/12/2026

325.14K→324.58K

Common Stock

Indirect

S · Sale

−135.00

Price / share

$554.46

Trade value

$74.85K

% of position

0.0%

10/12/2026

324.58K→324.44K

Total

Net shares

+0.00

Net value

-$4.11M

Security	Date	Type	Shares	Price / Share	Trade Value	% of Position	Held Before	Held After
Common Stock Indirect	10/12/2026	M · Option Exercise	+9.50K	$117.76	$1.12M	2.9%	324.44K	333.94K
Common Stock Indirect	10/12/2026	S · Sale	−428.00	$548.13	$234.60K	0.1%	333.94K	333.51K
Common Stock Indirect	10/12/2026	S · Sale	−1.33K	$549.01	$729.64K	0.4%	333.51K	332.19K
Common Stock Indirect	10/12/2026	S · Sale	−2.56K	$550.03	$1.41M	0.8%	332.19K	329.62K
Common Stock Indirect	10/12/2026	S · Sale	−2.63K	$551.10	$1.45M	0.8%	329.62K	326.99K
Common Stock Indirect	10/12/2026	S · Sale	−1.86K	$551.92	$1.02M	0.6%	326.99K	325.14K
Common Stock Indirect	10/12/2026	S · Sale	−558.00	$552.93	$308.53K	0.2%	325.14K	324.58K
Common Stock Indirect	10/12/2026	S · Sale	−135.00	$554.46	$74.85K	0.0%	324.58K	324.44K
Total			+0.00		-$4.11M

Derivative Transactions1

Stock Option

Indirect

M · Option Exercise

Converts to

Common Stock

9.50K shares

−9.50K

Strike price

117.76

Held after

252.41K

Exercisable

—

10/12/2026

Security	Converts To	Date	Type	Shares	Strike Price	Exercisable	Held After
Stock Option Indirect	Common Stock9.50K shares	10/12/2026	M · Option Exercise	−9.50K	117.76	—	252.41K

Non-Derivative Holdings (Post-Transaction)5

Common Stock

Indirect

Shares owned249.11K

Common Stock

Indirect

Shares owned45.60K

Common Stock

Indirect

Shares owned8.90K

Common Stock

Indirect

Shares owned166.00

Common Stock

Direct

Shares owned40.51K

Total

40.51K direct·303.77K indirect344.29K

Security Title	Shares Owned	Ownership Type
Common Stock	249.11K	Indirect
Common Stock	45.60K	Indirect
Common Stock	8.90K	Indirect
Common Stock	166.00	Indirect
Common Stock	40.51K	Direct
Total	344.29K	40.51K direct·303.77K indirect

Derivative Holdings (Post-Transaction)0

No derivative holdings reported